Mersana Therapeutics

company

About

Mersana Therapeutics develops a biodegradable polymer platform Fleximer® which creates new and better medicines.

  • 101 - 250

Details

Last Funding Type
Series C
Last Funding Money Raised
$33M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2005
Number Of Employee
101 - 250
Operating Status
Active

Mersana Therapeutics employs its biodegradable polymer platform to create new and better medicines. They are advancing their own clinical-stage pipeline of novel compounds with the potential to address multiple oncology indications.

It was founded in 2005 and headquartered in Cambridge, Massachusetts.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
$81M
Mersana Therapeutics has raised a total of $81M in funding over 2 rounds. Their latest funding was raised on Jun 16, 2016 from a Series C round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 16, 2016 Series C $33M 1 Detail
Jul 31, 2012 Series A $27M 1 Detail
Nov 8, 2005 Series Unknown $21M 2 Detail

Investments

Number of Investments
Number of Lead Investments
1
0
Mersana Therapeutics has made 1 investments. Their most recent investment was on Nov 21, 2012, when biNu raised $4.30M.
Date Company Name
Round Money Raised Industry Lead Investor
Nov 21, 2012 biNu
Series A $4.30M Apps

Investors

Number of Lead Investors
Number of Investors
4
Mersana Therapeutics is funded by 4 investors. Takeda and Harris and Harris Group are the most recent investors.
Investor Name Lead Investor Funding Round
Takeda Series C
Harris and Harris Group Series A
Lansing Brown Investments Series Unknown
Cape Family Fund Series Unknown